We collected information about Deciphera Pharmaceuticals Llc Hours for you. Follow the liks to find out everything about Deciphera Pharmaceuticals Llc Hours.
https://investorplace.com/2021/11/dcph-stock-is-trying-to-beat-financial-cancer-and-losing/
Deciphera Pharmaceuticals (NASDAQ:DCPH) is a biotech company that develops drugs mainly for the treatment of cancer. Right now, DCPH stock shares are down nearly 85% year-to-date (YTD), at $7.70 ...
https://investors.deciphera.com/news-releases/news-release-details/deciphera-pharmaceuticals-announce-third-quarter-2021-financial
WALTHAM, Mass.--(BUSINESS WIRE)--Oct. 26, 2021-- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that it will report its third quarter 2021 financial results on Tuesday, November 2, 2021. In connection with the earnings release, Deciphera’s management team will host a live conference call and webcast at 4:30 PM ET on Tuesday, November 2, …
https://www.nasdaq.com/market-activity/stocks/dcph/after-hours
Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://www.linkedin.com/company/deciphera-pharmaceuticals
Deciphera Pharmaceuticals | 17,478 followers on LinkedIn. Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to …
https://www.bizapedia.com/ma/deciphera-pharmaceuticals-llc.html
Deciphera Pharmaceuticals, LLC is a Massachusetts Foreign Limited-Liability Company (Llc) filed On September 30, 2014. The company's File Number is listed as 001148248. The Registered Agent on file for this company is National Registered Agents, Inc. and is located at 155 Federal St., Suite 700, Boston, MA 02110.
https://investorplace.com/2021/11/dcph-stock-alert-why-is-deciphera-pharmaceuticals-plunging-70/
For investors in Deciphera Pharmaceuticals (NASDAQ: DCPH) and DCPH stock, such appears to be the case today. This incredible daily move in DCPH stock is notable for a few reasons. Over the past ...
https://catchingnews.com/2021/11/05/why-deciphera-pharmaceuticals-inc-dcph-stock-is-gloomy-today/
Deciphera Pharmaceuticals, Inc. (DCPH) stock saw a huge decline following the announcement of topline results from the INTRIGUE phase 3 clinical study. DCPH stock price saw a downtrend of 74.11% to drop at $9.32 a share at the time of this writing. The stock was also gloomy in the previous trade and
https://www.investing.com/equities/deciphera-pharmaceuticals-news
Deciphera Pharmaceuticals (DCPH): Q3 GAAP EPS of -$1.37 misses by $0.09.Revenue of $23.22M (+50.3% Y/Y) misses by $0.35M.Press Release. Deciphera Pharmaceuticals (NASDAQ:DCPH) is scheduled to ...
https://www.marketwatch.com/story/deciphera-pharmaceuticals-cancer-drug-misses-primary-endpoint-271636110781
Deciphera Pharmaceuticals Inc.'s Phase 3 study testing its Qinlock drug in some people with gastrointestinal stromal tumor did not meet its primary endpoint, the company said Friday. The study was ...
https://au.finance.yahoo.com/news/deciphera-pharmaceuticals-inc-present-upcoming-110000014.html
Deciphera Pharmaceuticals, Inc. [email protected]. 781-906-1112. Media: David Rosen. Argot Partners. [email protected]. 212-600-1902. Our goal is to create a safe and engaging place for users to connect over interests and passions.
Searching for Deciphera Pharmaceuticals Llc Hours?
You can just click the links above. The info is collected for you.
